Cargando…

Early TRAIL-engagement elicits potent multimodal targeting of melanoma by CD34(+) progenitor cell-derived NK cells

Umbilical cord blood (UCB) CD34(+) progenitor cell-derived natural killer (NK) cells exert efficient cytotoxicity against various melanoma cell lines. Of interest, the relative cytotoxic performance of individual UCB donors was consistent throughout the melanoma panel and correlated with IFNγ, TNF,...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Vliet, Amanda A., Peters, Ella, Vodegel, Denise, Steenmans, Daniëlle, Raimo, Monica, Gibbs, Susan, de Gruijl, Tanja D., Duru, Adil D., Spanholtz, Jan, Georgoudaki, Anna-Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329179/ https://www.ncbi.nlm.nih.gov/pubmed/37426355 http://dx.doi.org/10.1016/j.isci.2023.107078

Ejemplares similares

Adoptive NK Cell Therapy: A Promising Treatment Prospect for Metastatic Melanoma
por: van Vliet, Amanda A., et al.
Publicado: (2021)

Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
por: Lamers-Kok, Nina, et al.
Publicado: (2022)

High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status
por: Veluchamy, John P., et al.
Publicado: (2016)

Boosting Natural Killer Cell Therapies in Glioblastoma Multiforme Using Supramolecular Cationic Inhibitors of Heat Shock Protein 90
por: Saha, Tanmoy, et al.
Publicado: (2021)

Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer
por: Veluchamy, John Pradeep, et al.
Publicado: (2016)

Standardized and flexible eight colour flow cytometry panels harmonized between different laboratories to study human NK cell phenotype and function
por: Veluchamy, John P., et al.
Publicado: (2017)

Enhancement of NK Cell Antitumor Effector Functions Using a Bispecific Single Domain Antibody Targeting CD16 and the Epidermal Growth Factor Receptor
por: Toffoli, Elisa C., et al.
Publicado: (2021)

In Vivo Efficacy of Umbilical Cord Blood Stem Cell-Derived NK Cells in the Treatment of Metastatic Colorectal Cancer
por: Veluchamy, John P., et al.
Publicado: (2017)

Clinically applicable CD34(+)-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses
por: van Eck van der Sluijs, Jesper, et al.
Publicado: (2021)

Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process
por: Spanholtz, Jan, et al.
Publicado: (2011)

Blockade of the immunosuppressive KIR2DL5/PVR pathway elicits potent human NK cell–mediated antitumor immunity
por: Ren, Xiaoxin, et al.
Publicado: (2022)

The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
por: Veluchamy, John P., et al.
Publicado: (2017)

IL-25 elicits a multi-potent progenitor cell population that promotes Th2 cytokine responses
por: Saenz, Steven A., et al.
Publicado: (2010)

In vitro generation of allo-reactive human NK cells from umblillical cord blood CD34+ progenitor cells
por: Ahn, Yong-Oon, et al.
Publicado: (2015)

Good manufacturing practice production of CD34(+) progenitor-derived NK cells for adoptive immunotherapy in acute myeloid leukemia
por: de Jonge, P. K. J. D., et al.
Publicado: (2023)

Commitment of Common T/Natural Killer (Nk) Progenitors to Unipotent T and Nk Progenitors in the Murine Fetal Thymus Revealed by a Single Progenitor Assay
por: Ikawa, Tomokatsu, et al.
Publicado: (1999)

Dengue Virus Induces NK Cell Activation through TRAIL Expression during Infection
por: Gandini, Mariana, et al.
Publicado: (2017)

Non‐apoptotic TRAIL function modulates NK cell activity during viral infection
por: Cardoso Alves, Ludmila, et al.
Publicado: (2019)

Natural Killer (NK) Cell–mediated Cytotoxicity: Differential Use of TRAIL and Fas Ligand by Immature and Mature Primary Human NK Cells
por: Zamai, Loris, et al.
Publicado: (1998)

IL-12 Directs Further Maturation of Ex Vivo Differentiated NK Cells with Improved Therapeutic Potential
por: Lehmann, Dorit, et al.
Publicado: (2014)

Generation of a Novel Regulatory NK Cell Subset from Peripheral Blood CD34(+) Progenitors Promoted by Membrane-Bound IL-15
por: Giuliani, Massimo, et al.
Publicado: (2008)

Identification of Novel Human NK Cell Progenitor Subsets
por: Sathe, Priyanka, et al.
Publicado: (2017)

Hepatocyte-specific NEMO deletion promotes NK/NKT cell– and TRAIL-dependent liver damage
por: Beraza, Naiara, et al.
Publicado: (2009)

TRAIL-producing NK cells contribute to liver injury and related fibrogenesis in the context of GNMT deficiency
por: Fernández-Álvarez, Sara, et al.
Publicado: (2014)

TRAIL-dependent apoptosis of peritoneal mesothelial cells by NK cells promotes ovarian cancer invasion
por: Steitz, Anna Mary, et al.
Publicado: (2023)

Pro-apoptotic effect of TRAIL-transfected endothelial progenitor cells on glioma cells
por: Deng, Xin, et al.
Publicado: (2018)

Identification of miR-34a as a potent inhibitor of prostate cancer progenitor cells and metastasis by directly repressing CD44
por: Liu, Can, et al.
Publicado: (2011)

Multimodal immersive trail making-virtual reality paradigm to study cognitive-motor interactions
por: Plotnik, Meir, et al.
Publicado: (2021)

Inhibition of the TRAIL Death Receptor by CMV Reveals Its Importance in NK Cell-Mediated Antiviral Defense
por: Verma, Shilpi, et al.
Publicado: (2014)

IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34(+) progenitor-derived NK cells
por: Van der Meer, J. M. R., et al.
Publicado: (2020)

Advances in clinical NK cell studies: Donor selection, manufacturing and quality control
por: Koehl, U., et al.
Publicado: (2015)

Defining Early Human NK Cell Developmental Stages in Primary and Secondary Lymphoid Tissues
por: Eissens, Diana N., et al.
Publicado: (2012)

Upregulation of endogenous TRAIL-elicited apoptosis is essential for metformin-mediated antitumor activity against TNBC and NSCLC
por: Liu, Shuang, et al.
Publicado: (2021)

Extensive natural killer cell receptor phenotyping on NK and T cells discloses differences in RA and PsA, potentially mirroring diverse immunoregulatory functions
por: van Bijnen, Sandra TA, et al.
Publicado: (2011)

Potent antitumoral activity of TRAIL through generation of tumor-targeted single-chain fusion proteins
por: Schneider, B, et al.
Publicado: (2010)

Acute portal hypertension using portal vein ligation abrogates TRAIL expression of liver‐resident NK cells
por: Imaoka, Yuki, et al.
Publicado: (2022)

Adipocytokines and CD34(+) Progenitor Cells in Alzheimer's Disease
por: Bigalke, Boris, et al.
Publicado: (2011)

Natural Killer Cells and Anti-Cancer Therapies: Reciprocal Effects on Immune Function and Therapeutic Response
por: Toffoli, Elisa C., et al.
Publicado: (2021)

Correction to: IL‑15 superagonist N‑803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor‑derived NK cells
por: Van der Meer, J. M. R., et al.
Publicado: (2021)

CD34(+) progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rg(null) mice
por: Van der Meer, Jolien M.R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0b7cuqcfks8iqn2p87rkgqvgas